Cryoneurolysis Versus Bipolar Radiofrequency Ablation of Genicular Nerves for Pain Relief in Symptomatic Knee Osteoarthritis
- NCT ID
- NCT07855367
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- National Cancer Institute, Egypt
- Conditions
- Bipolar Radiofrequency Ablation, Cryoneurolysis, Genicular Nerves, Knee Osteoarthritis, Pain Relief, Symptomatic
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: Ultrasound-Guided Cryoneurolysis Versus Bipolar Radiofrequency Ablation of Genicular Nerves for Pain Relief in Symptomatic Knee Osteoarthritis: A Randomized Controlled Trial
Enrollment: 30 participants (Estimated).
What is being studied
- Procedure: Bipolar radiofrequency ablation
- Procedure: Ultrasound-guided cryoneurolysis
Who may be eligible
- Ages
- 40 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: Egypt
Sample of listed locations
- Cairo University — Cairo, 12613, Egypt — Recruiting
Study details
- Start date
- September 15, 2026
- Primary completion date
- March 15, 2027
- Completion date
- March 15, 2027
- First posted
- October 2, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07855367
- Registry last updated
- October 2, 2026
- QualifiedStudies registry data refreshed
- October 5, 2026
- QualifiedStudies record fetched
- October 5, 2026
View NCT07855367 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Knee Pain studies | Clinical trial FAQ